psoriasis

PARIS — Doses of interleukin (IL)-17 and IL-23 inhibitors were safely reduced in people with plaque psoriasis who had “very stable low disease activity”; it was reported during a late-breaking news session last week at the European Academy of Dermatology and Venereology (EADV) 2025 Congress. “We showed a stepwise dose reduction of IL-17 and IL-23 inhibitors is noninferior […]

by Lori Solomon edited by Stephanie Baum, reviewed by Alexander Pol  Editors’ notes  The GIST Add as preferred source Consuming a greater proportion of nutrients from plant sources may aid management of psoriasis symptoms, according to a study published online Feb. 19 in the European Journal of Nutrition. Sylvia Zanesco, Ph.D., from King’s College London, and colleagues assessed macronutrient intakes

by Spanish National Research Council edited by Sadie Harley, reviewed by Robert Egan  Editors’ notes  The GIST Add as preferred source Graphical abstract. Credit: ACS Central Science (2025). DOI: 10.1021/acscentsci.5c00987 Researchers from the Institute for Advanced Chemistry of Catalonia (IQAC) of the Spanish National Research Council (CSIC) have developed a series of light-activatable drug candidates that could serve as a

by Medical University of Vienna edited by Gaby Clark, reviewed by Robert Egan  Editors’ notes Representative images of H&E staining of back skin (left) and histological quantification of the dermal white adipose tissue (DWAT) area (right). Credit: Cell Death & Differentiation (2025). DOI: 10.1038/s41418-025-01630-4 A research team led by Erwin F. Wagner from the Medical University of Vienna has discovered

Ted Bosworth November 12, 2025 Icotrokinra, a novel oral interleukin (IL)-23 inhibitor, provided a level of response in moderate-to-severe plaque psoriasis that is similar to that previously reported with injectable biologics, according to 16-week results from a newly published phase 3 trial. In a population with a median baseline Psoriasis Area and Severity Index (PASI)

by VIB (the Flanders Institute for Biotechnology) edited by Sadie Harley, reviewed by Robert Egan Graphical abstract. Credit: EMBO Molecular Medicine (2025). DOI: 10.1038/s44321-025-00321-4 A mutation previously linked to skin disorders like psoriasis may also play a surprising role in gut health, according to new research published by scientists at VIB-UGent and colleagues from UGent, the University of Barcelona, and